Meeting Abstract RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- INTRAEPIDERMAL NERVE FIBER DENSITY RELATIONSHIP TO NEUROLOGIC AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH V30M TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY
- INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM CAUSES MEANINGFUL IMPROVEMENT IN MEN WITH PEYRONIE'S DISEASE: THE RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS
- Intravaginal DHEA, the Physiological and Highly Efficient Treatment of Vaginal Atrophy
- Introducing New Integral Parameter for Biomechanical Characterization of the Female Pelvic Floor
- Investigating Fetal Development Using 3D Ultrasounds: Applications to Understanding the Developmental Impacts of Exposure to Endocrine-Disrupting Chemicals
- Investigating HIV-1 TAT protein role in Atherogenesis
- Investigating the communication processes and effect of regulatory requirements on communication between physicians and skilled home health care agencies
- Investigating the role of B cell signaling in atherosclerosis
- IOPS-Guided Antegrade In-Situ Laser Fenestration in an Aortic Model
- IS ANTI-NXP2 AUTOANTIBODY A RISK FACTOR FOR CALCINOSIS AND POOR OUTCOME IN JUVENILE DERMATOMYOSITIS PATIENTS?
- IS EPWORTH SLEEPINESS SCORE RELIABLE AS A SCREENING TOOL FOR OSA?
- IS IT TIME TO STOP PERFORMING ROUTINE ENDOSCOPIC SPHINCTEROTOMIES WHEN PLACING BILIARY STENTS? A SYSTEMATIC REVIEW AND META-ANALYSIS
- Is It Worth It? Distal Revascularization and Interval Ligation for Management of Dialysis Access Steal Syndrome
- Is There Ever an Indication for Hormone Therapy in an Asymptomatic Postmenopausal Woman?
- IS THICKER BETTER? ENDOMETRIAL THICKNESS AT THE TIME OF INTRAUTERINE INSEMINATION.
- ISOLATED AMYLOIDOMA OF THE LUNG
- Isthmocele repair: a combined hysteroscopic and laparoscopic approach
- IVF program success influenced by variability in day 3 embryo grading.
- Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial
- Khorana Risk Score for Thrombosis Prediction in Patients with Gynecologic Malignancies Using Immune Checkpoint Inhibitors- a Real-World Validation
- Kinetic Characterization of the Mitochondrial Transporter Human Myosin XIX
- Labor patterns do not predict complications in patients with vaginal birth after cesarean
- Lack of diversity in hidradenitis suppurativa clinical trials: A cross-sectional analysis
- Lacritin, a Novel Tear Glycoprotein, is an Effective Topical Treatment in Dry Eye Animal Models
- Lacritin, a Novel Tear Glycoprotein, Stimulates Tear Production in Rabbits without Ocular Toxicity
- Language Variant of Atypical Alzheimer's Disease: A Case Study
- Lanreotide Depot/Autogel for Symptomatic Control of Carcinoid Syndrome (CS) in Patients With Neuroendocrine Tumors (NETs) Previously Responsive to Octreotide: Subanalysis of Patient-Reported Symptoms From the Phase 3 ELECT Study
- Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naive or -Experienced Patients
- Lanreotide for the Prolonged Control of Carcinoid Syndrome (CS) in Somatostatin Analog (SSA)-Naive or -Experienced Patients
- Laparoscopic myomectomy: when and how?